pharmaceutical investing Sorrento and Celularity to Start Anti-CD38 CAR-T Phase 1 Clinical Trial in Patients With Relapsed or Refractory Multiple Myeloma
Prismo Metals Announces Closing of Upsized Private Placement Silver King Exploration to Begin in July